Major Research Results
- Home
- Major Research Results
-
2019
- Introduction of “ChOH” production
- “Guaiacol” synthesis research development
- New “COX-2” synthesis research development
-
2018
- Inroduction of “Doxazosin mesylate” production
- “ChOH” new manufacture method development
- “Paliperidone” new synthesis patent registration
-
2017
- “Paliperidone” new synthesis research
- “Doxazosin mesylate” synthesis development
- “Tetrahydrozoline” synthesis research
-
2016
- “Paliperidone” key intermediate synthesis research
- “Trientin” synthesis research
- “Bepostatin” intermediate synthesis research
-
2015
- “Benfotiamin” intermediate synthesis research
- Government technology innovation project research (schizophrenia medicine)
- “Teicoplanin” manufacture technique research
-
2014
- Joint research development with Center for
Nutraceutical and Pharmaceutical Materials on
anti-tuberculosis drug
- “Bepostatin” patent exclusive license contract
- “Aceclofenac” new process development
-
2006~2013
- Gastrointestinal regulator, “Itopride HCl”
development
- Development of cure for benign prostatic hyperplasia, “Tolterodine”
- Diuretics, “Torasemide” development
- Anti-cancer drug “Capecitabine” development
- Development of cure for asthma “Pranklukast” and
“Etofylline nicotinate”
- Antihistamines, “Bepostatin” new salt research
and synthesis development
- Industrialization of “Bepostatin” as well as
patent application
- “Chromic chloride” synthesis research
-
2001~2005
- Antihistamines, “Ebastine” development
- Development of cure for avian influenza, “Oseltamivir Phosphate” (Tamiflu)
- Anticoagulant, “Warfarin Sodium” developement
- Antibiotics, “Teicoplanin” development
- Development of cure for
hypertension, “Doxazosin Mesylate”
- Development of cure for skin
disease, “Prednicarbate”
- Digestive medicine, “Alibendol” development
- Development of cure for asthma,
“Bambuterol HCl”